In the latest episode of the Swedish American Chamber of Commerce in New England (SACC-NE) podcast, the discussion explores Nordic life science innovation in the U.S., featuring Swedish biotechnology company Diamyd Medical and its work to develop an immunotherapy aimed at preserving the body’s own insulin production in type 1 diabetes.
Guest Dr. Karin Rosén, physician-scientist, SACC member, and Diamyd Medical board member, shares insights from her experience in global biopharma. The conversation is moderated by strategic communications executive Julie Ames in collaboration with Ventures Accelerated.
Listen to the podcast here